1. Inhibition of L-lactate transport into rat erythrocytes by stilbenedisulphonates was studied under conditions which allowed the contribution of reversible and irreversible inhibition to be assessed. 2. At low temperatures (7°C), 4,4'-diisothiocyanostilbene-2,2'-disulphonate (DIDS) and other stilbenedisulphonates were found to inhibit lactate transport instantaneously, in a manner which was fully reversible. The most potent reversible inhibitors were 4,4'-dibenzamidostilbene-2,2'-disulphonate (DBDS), DIDS and 4-acetamido-4'-isothiocyanostilbene-2,2'-disulphonate causing 50 % inhibition) for irreversible inhibition by both compounds was approx. 100 /uM. SITS was much less potent as an irreversible inhibitor of L-lactate transport, approx. 20 % inhibition being obtained at 1000 gM. 5. The reversible inhibitor DBDS (1 mM) afforded protection against irreversible inhibition by DIDS and H2DIDS (100,uM); protection was 60 and 65 % respectively after a 60 min incubation. This indicates that specific binding of the irreversible inhibitors is required before covalent modification can take place. 6. These compounds may be useful high-affinity probes for lactate transport in other tissues and might act as affinity labels for the transport protein(s).
INTRODUCTION
Stilbenedisulphonates are among the most potent inhibitors of inorganic anion exchange in erythrocytes (Cabantchik & Rothstein, 1972; Cabantchik et al., 1978) . The most effective of these compounds are 4,4'-di-isothiocyanostilbene-2,2'-disulphonic acid (DIDS) and its dihydro derivative (H2DIDS). These compounds initially inhibit anion transport in a reversible manner, with K1 values of approx. 0.03 /M and 0.04-0.05 uM respectively (Shami et al., 1978; Janas et al., 1989) . Subsequent to this binding step, one of the isothiocyanate groups on the inhibitor reacts with the c-amino group of a lysine residue on the transporter, rendering the inhibition irreversible (see Passow, 1986) . This has allowed [3H]DIDS and [3H]H2DIDS to be used as affinity labels for the erythrocyte anion transporter, and thus has enabled the identification of band 3 (nomenclature according to Fairbanks et al., 1971) as the protein responsible (Cabantchik & Rothstein, 1974; Lepke et al., 1976; Ship et al., 1977) . Other stilbenedisulphonate derivatives, which do not possess the reactive isothiocyanate group, inhibit anion transport in a manner which is fully reversible (see Cabantchik et al., 1978) .
Lactate and a variety of other short-chain monocarboxylates are transported across the plasma membrane of mammalian erythrocytes by three parallel pathways: (1) a specific H+/monocarboxylate co-transporter (which accounts for > 90 % of transport at physiological concentrations of L-lactate), (2) band 3 and (3) diffusion of the free acid (Halestrap, 1976; Deuticke et al., 1978 Deuticke et al., , 1982 . Deuticke et al. (1982) found that DIDS, at concentrations just sufficient for maximal inhibition of inorganic anion transport via band 3, had almost no effect on lactate transport. However, Jennings & Adams-Lackey (1982) reported that incubation with a higher (100 /tM) concentration of H2DIDS, for 1 h at 37°C, resulted in approx. 80 % inhibition of the specific monocarboxylate carrier in rabbit erythrocytes. These workers showed the inhibition to be irreversible, and used [3H]H2DIDS to label a broad band of 43-60 kDa on SDS/PAGE in parallel with inhibition of transport (Jennings & Adams-Lackey, 1982; Donovan & Jennings, 1985 . We have also found the amino-reactive stilbenedisulphonate DIDS (500 #M) to inhibit the monocarboxylate transporters of hepatocytes and heart cells by approx. 50 and 70 % respectively (Edlund & Halestrap, 1988; Poole et al., 1989) . It is unclear from previous work whether DIDS and dihydro-DIDS interact specifically with monocarboxylate transporters or whether inhibition is a consequence of a more general reactivity of isothiocyanates with susceptible amino groups. The erythrocyte monocarboxylate carrier is known to be inhibited by a variety of amino reagents (Halestrap, 1976; Donovan & Jennings, 1986) .
Here we present a more detailed investigation of the effects of stilbenedisulphonates on the specific monocarboxylate carrier of rat erythrocytes. Our data show that some of these compounds are potent reversible inhibitors of this transporter. The structureactivity relationships for a range of these compounds are discussed. We also examine the relationship between reversible and irreversible inhibition of L-lactate transport by the reactive isothiocyanate derivatives.
EXPERIMENTAL

Materials
Unless stated otherwise, all chemicals and biochemicals were obtained from the sources given previously (Poole & Halestrap, 1988; Poole et al., 1990) . 4,4'-Diaminostilbene-2,2'-disulphonic Vol. 275 Abbreviations used: DIDS, 4,4'-di-isothiocyanostilbene-2,2'-disulphonate; H2DIDS, 4,4'-di-isothiocyanodihydrostilbene-2,2'-disulphonate; SITS, 4-acetamido-4'-isothiocyanostilbene-2,2'-disulphonate; DADS, 4,4'-diaminostilbene-2,2'-disulphonate; DAzDS, 4,4'-diazidostilbene-2,2'-disulphonate; DNDS, 4,4'-dinitrostilbene-2,2'-disulphonate; DBDS, 4,4'-dibenzamidostilbene-2,2'-disulphonate. (Halestrap, 1976 In some experiments lactate transport was monitored by measuring the proton flux that accompanies transport of lactate on the monocarboxylate carrier (Dubinsky & Racker, 1978 ; Leeks & Halestrap, 1979) . This was achieved using a standard combination pH electrode to measure extracellular pH in a suspension of erythrocytes, prepared as described above, but suspended in a lightly buffered citrate medium (84 mM-sodium citrate/I mM-EGTA, adjusted to pH 7.4 with NaH2PO4). Data acquisition was performed with a microcomputer.
Unless stated otherwise, all results are typical of at least two experiments on different cell preparations. Where kinetic data were fitted to appropriate equations, this was performed by using non-linear least-squares regression analysis. Any additions or modifications to the methods are given in the Figure legends.
RESULTS AND DISCUSSION
Irreversible inhibition of L-lactate transport in rat erythrocytes by DIDS, H2DIDS and SITS
In Fig. 1 we show the inhibition of transport of 0.5 mM-Llactate into rat erythrocytes after incubation for 1 h at 37°C with different concentrations of DIDS, H2DIDS and SITS. These compounds all contain at least one isothiocyanate group, which enables them to react with susceptible amino groups. The data of Fig. 1 1c) . This difference between total and irreversible inhibition indicates that, at least for SITS, some inhibition of transport can occur by a reversible interaction with the carrier. It is noteworthy that the extent of irreversible inhibition of band 3-mediated inorganic-anion exchange by SITS is also much less than that observed for DIDS and H2DIDS, even after prolonged incubation at 37°C (Cabantchik & Rothstein, 1972) .
In Fig. 2 we show a time course for the onset of irreversible inhibition of the rat erythrocyte monocarboxylate transporter by 500 /tM-DIDS. Under these conditions 50 % inhibition required approx. 10 min to develop, but the extent of inhibition at 60 min was less than predicted on the basis of strict first-order kinetics.
A much better fit was obtained if an additional parameter was included, representing a component of transport which was not inhibited, even after prolonged incubation. A component of inorganic-anion transport which is apparently insensitive to irreversible inhibition by isothiocyanates has previously been reported (Rakitzis et al., 1978) . Such observations may also be explained by removal of reactive DIDS from solution. Hydrolysis of isothiocyanates to unreactive amino derivatives and reaction with amino groups of phospholipids on the surface of the erythrocyte membrane are known to occur (see Cabantchik & Rothstein, 1972; Ho & Guidotti, 1975) . (Fig. 3a, traces ii and iv) . The level of inhibition observed was not increased if cells were preincubated with 100 /SM-DIDS for 2 min at 7°C (trace iii). The data of Suspensions of rat erythrocytes at 10 % haematocrit were incubated for 1 h at 37°C with the concentrations of (a) DIDS, (b Fig. 3(a) was similar to total inhibition after prolonged incubation
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Rat erythrocytes at 10 % haematocrit and 37°C were mixed with 500 /M (final concn.)-DIDS. Samples were withdrawn at the times indicated, and reversibly bound inhibitor was removed as described under 'Methods'. The L-lactate transport activity of each sample was then determined.
at 37°C (see Fig. la ). Rapid reversal of inhibition could be achieved by addition of BSA as shown in Fig. 3 potent known inhibitor of band 3 (Janas et al., 1989) . Our data indicate that DBDS and DIDS are two of the most potent known reversible inhibitors of the erythrocyte monocarboxylate carrier, with K, values similar to, or lower than, the most effective of the a-cyanocinnamate derivatives (Halestrap, 1976; Poole et al., 1990) .
To determine the nature of reversible interaction of stilbenedisulphonates with the rat erythrocyte lactate transporter, the effects of substrate concentration on the kinetics of inhibition were investigated. In Fig. 5 we show the kinetics of reversible inhibition of L-lactate transport by DIDS and DBDS at three different concentrations of the substrate. The data are presented in the form of comparative Dixon plots and demonstrate that the apparent Ki values for inhibition of L-lactate transport increase as the concentration of L-lactate is increased. At 0.5 mm-, 2.5 mMand 6 mM-L-lactate, apparent Ki values for inhibition by DIDS were 50+2.1, 87+2.9 and 124+ 1.7 #M respectively (means + S.E.M. for four experiments). These data provide a clear indication that inhibition is largely competitive. When the data from four separate experiments were fitted to the equation for competitive inhibition, which in three out of four experiments gave as good a statistical fit as for mixed inhibition, the mean derived K1 value (± S.E.M.) was 39.5 + 5.7 /aM and the Km value was 2.5 +0.51 mm. The Km value is very similar to that reported previously (Edlund & Halestrap, 1988; Poole et al., 1990) . For DBDS, competitive K, values were determined as 22.5 + 2.7 /LM and 22.4 + 1.9 /tM in two experiments (means + S.E.M.).
Protection, by DBDS, against irreversible inhibition of lactate transport caused by DIDS and H2DIDS
We have shown that DIDS and H2DIDS can inhibit lactate transport reversibly and that, upon prolonged incubation, irreversible inhibition develops. However, these observations do not necessarily imply that covalent modification occurs at the same site as the reversible interaction. If this were the case, then reversible inhibitors should be able to protect against irreversible inhibition by DIDS and H2DIDS. In Table 2 we show that DBDS (I mM) afforded considerable protection (approx. 60%) against irreversible inhibition of L-lactate transport after incubation of rat erythrocytes with 100 1sM-DIDS or -H2DIDS for 60 min at 37 'C. The protection was slightly greater (70-75 %) at 30 min.
General conclusions
In the present paper we have shown that a variety of stilbenedisulphonates are reversible inhibitors of the specific monocarboxylate transporter in rat erythrocytes. It is perhaps (iii) (ii) (i) 0.5 min Table 1 . Kinetic parameters for reversible inhibition of L-lactate transport in rat erythrocytes by stilbenedisulphonate derivatives
The data from experiments performed as described for Fig. 4 between different pathways of monocarboxylate transport. Some workers have used 0.5-1.0 mM-DIDS or -SITS to inhibit transport of inorganic anions in various tissues when studying processes involving monocarboxylate transport (Rice & Steck, 1977; Siebens & Boron, 1989 erythrocytes (see Edlund & Halestrap, 1988; . It is a more stable compound than the isothiocyanate derivatives, which also suffer the disadvantage of reacting nonspecifically with amino groups. The Ki value for DBDS is similar to those of the most effective a-cyanocinnamate derivatives in erythrocytes (Halestrap, 1976; Poole et al., 1990) , but these inhibitors can enter cells and interfere with metabolism of lactate and pyruvate at the level of mitochondrial pyruvate transport (Halestrap & Denton, 1975 ; Thomas & Halestrap, 1981) . Other inhibitors of monocarboxylate transport, such as p-chloromercuribenzenesulphonate and quercetin, have many nonspecific effects [see Suolinna et al. (1975) , Salter et al. (1978) and Deuticke (1986) ]. Thus the membrane-impermeant DBDS may prove useful in studies to determine the importance and possible regulatory role of plasma-membrane lactate/pyruvate transport in a variety of tissues. Those stilbenedisulphonates which possess an isothiocyanate group can subsequently react with the transporter, causing irreversible inhibition. Reversible binding of the inhibitor to the exofacial substrate binding site (or a site interacting with it), appears to be a prerequisite for such covalent modification. Thus these compounds can be regarded as affinity labels for the carrier. Jennings and co-workers (Jennings & Adams-Lackey, 1982; Donovan & Jennings, 1985) found a rabbit erythrocyte membrane protein of 43-60 kDa to be labelled by [3H]H2DIDS in parallel with inhibition of L-lactate transport. Clearly, such circumstancial evidence for an involvement of this protein in the transport process would be strengthened if DBDS or substrates of the transporter could afford protection against labelling of the carrier. DIDS and H2DIDS, and the potent reversible inhibitor DBDS, may also prove to be useful probes for the specific monocarboxylate transporter in other cells.
